April 2020 Anthem Provider News - Georgia

Contents

AdministrativeCommercialApril 1, 2020

Information from Anthem for Care Providers about COVID-19

AdministrativeCommercialApril 1, 2020

Provider transparency update

AdministrativeCommercialApril 1, 2020

Anthem acquires Beacon Health Options

AdministrativeCommercialApril 1, 2020

Anthem continues focus on updates to our public provider website

Policy UpdatesCommercialApril 1, 2020

MCG care guidelines 24th edition

State & FederalMedicare AdvantageApril 1, 2020

Medical drug benefit Clinical Criteria updates November 2019

State & FederalMedicare AdvantageApril 1, 2020

2020 Medicare risk adjustment provider trainings

State & FederalMedicare AdvantageApril 1, 2020

Medical drug benefit Clinical Criteria updates December 2019

State & FederalMedicare AdvantageApril 1, 2020

Keep up with Medicare news

AdministrativeCommercialApril 1, 2020

Provider transparency update

A key goal of Anthem’s provider transparency initiatives is to improve quality while managing health care costs. One of the ways is through Anthem’s value-based programs such as Enhanced Personal Health Care, Bundled Payment Programs, Oncology Medical Home, and so on – called the “Programs.”  Certain providers (“Value-Based Program Providers” also known as “Payment Innovation Providers”) in Anthem’s various value-based programs receive quality, utilization and/or cost data, reports, and information about the health care providers (“Referral Providers”) to whom the Value-Based Program Providers may refer their patients covered under the Programs. If a Referral Provider is higher quality and/or lower cost, this component of the Programs should result in the provider getting more referrals from Value-Based Program Providers. The converse should be true if Referral Providers are lower quality and/or higher cost.

Providing this type of data, including comparative cost information, to Value Based Program Providers helps them make more informed decisions about managing health care costs and maintaining and improving quality of care. It also helps them succeed under the terms of the Programs.

 

Additionally, employers and group health plans (or their representatives or vendors) may also be given quality/cost/utilization information about Value Based Program Providers and Referral Providers so that they can better understand how their health care dollars are being spent and how their health benefits plans are being administered. This will, among other things, give them the opportunity to educate their employees and plan members about the benefits of using higher quality and/or lower cost health care providers.

 

Anthem will share data on which it relied in making these quality/cost/utilization evaluations upon request, and will discuss it with Referral Providers - including any opportunities for improvement. For questions or support, please refer to your local Market Representative or Care Consultant.

AdministrativeCommercialApril 1, 2020

HEDIS 2020 Federal Employee Program® medical record request requirements

Centauri Health Solutions is the contracted vendor to gather member medical records on behalf of the Blue Cross and Blue Shield Federal Employee Program. We value the relationship with our providers, and ask that you respond to the detailed requests in support of risk adjustment, HEDIS and other government required activities within the requested timeframe. Centauri Health will work with you to obtain records via fax, mail, remote electronic medical record (EMR) access, or onsite scanning/EMR download (as necessary). We ask that you please promptly comply within five (5) business days of the record requests. If you have any questions, please contact Ify Ifezulike with Blue Cross Blue Shield Federal Employee Program at (202) 626-4839 or Mary Kay Sander with Centauri at (636) 333-9145.

AdministrativeCommercialApril 1, 2020

Anthem acquires Beacon Health Options

Anthem completed its acquisition of Beacon Health Options, a large behavioral health organization that serves more than 36 million people across the country. The company will operate as a wholly owned subsidiary of Anthem.

Bringing together our existing solid behavioral health business with Beacon’s successful model and support services creates one of the most comprehensive behavioral health networks in the country. It’s also an opportunity to offer best-in-class behavioral health capabilities and whole person care solutions in new and meaningful ways to help people live their best lives.

From the standpoint of our customers and providers at this time, it’s business as usual:
  • Members should continue to call the customer service number on the back of their membership card or access their health plan’s website for online self-service.
  • Providers should continue to use the provider service contact information, websites and online self-service portals as part of their agreement with either Anthem or Beacon.
  • There will be no immediate changes to the way Anthem or Beacon manage their respective provider networks, contracts and fee arrangements. Anthem and Beacon provider networks, contracts and fee arrangements will remain separate at this time.


We know our providers continue to expect more of their healthcare partner, and at Anthem, we aim to deliver more in return.


For more details, please see the press release.

AdministrativeCommercialApril 1, 2020

Anthem continues focus on updates to our public provider website

At Anthem, we continue to make changes to our public provider website to make it easier for you to find the information you need. The end of Q1 brings a few updates for the site at anthem.com:
  • Information has been added to our website regarding Patient-Centered Specialty Care (PCSC) – Anthem’s value-based payment program for cardiology, endocrinology and obstetrics/gynecology providers. You can find this information online as an extension of our broader patient-centered, value-based care program – Enhanced Personal Health Care (EPHC).
  • Documents listed on the Prior Authorization page can be conveniently accessed via online links.
  • Medicare Advantage will be live in the coming days. You will be able to view updated Medicare Advantage pages on the commercial public sites.
  • Medical Policies (MP) and Clinical Utilization Management Guidelines (CUMG) now display on our newly designed Web pages.


If you have any questions, please contact Michelle Fraser at michelle.fraser@anthem.com or Nick Kizirnis at nick.kirzinis@anthem.com

Policy UpdatesCommercialApril 1, 2020

MCG care guidelines 24th edition

Effective July 1, 2020, we will upgrade to the 24th edition of MCG care guidelines for the following modules: Inpatient & Surgical Care (ISC), General Recovery Care (GRC), Chronic Care (CC), Recovery Facility Care (RFC), and Behavioral Health Care (BHC). The below tables highlight new guidelines and changes that may be considered more restrictive.

 

Goal Length of Stay (GLOS) Changes for Inpatient & Surgical Care (ISC) and Behavioral Health Care (BHC)

Guideline

MCG Code

24th Edition GLOS

23rd Edition GLOS

Aortic Valve Replacement, Transcatheter

S-1320 

2 days postoperative

3 days postoperative

Appendectomy, with Abscess or Peritonitis, by Laparoscopy

S-185

Ambulatory or 2 days postoperative

2 days postoperative 

Appendectomy, without Abscess or Peritonitis, by Laparoscopy

S-175

Ambulatory postoperative

Ambulatory or 1 day postoperative 

Repair of Pelvic Organ Prolapse

S-1020

Ambulatory postoperative

Ambulatory or 1 day postoperative 

Urethral Suspension Procedures

S-850

Ambulatory postoperative

Ambulatory or 1 day postoperative 

Appendectomy, with Abscess or Peritonitis, by Laparoscopy, Pediatric

P-30

Ambulatory or 2 days postoperative

2 or 3 days postoperative 

Appendectomy, without Abscess or Peritonitis, by Laparoscopy, Pediatric

P-20

Ambulatory postoperative

Ambulatory or 1 day postoperative 

Tibial Osteotomy, Child or Adolescent

S-1131

Ambulatory or 1 day postoperative

1 day postoperative 

Schizophrenia Spectrum Disorders, Adult: Inpatient Care

B-014-IP

5 days

6 days

Schizophrenia Spectrum Disorders, Child or Adolescent: Inpatient Care

B-027-IP

5 days

6 days

Transcranial Magnetic Stimulation

B-801-T

Utilize B-801-T for Clinical Indications for procedure

Refer to BEH.00002 for Clinical Indications for procedure

 

New Optimal Recovery Guidelines (ORGs) for Inpatient & Surgical Care (ISC) and New Behavioral Health Care (BHC) New Guidelines

Body System

Guideline Title

MCG - Code

Pediatrics

Appendectomy, with Abscess or Peritonitis, Pediatric

P-35

Pediatrics

Appendectomy, without Abscess or Peritonitis, Pediatric

P-25

Home Care Behavioral Health

Attention-Deficit and Disruptive Behavior Disorders

B-003-HC

Home Care Behavioral Health

Autism Spectrum Disorders

B-012-HC


Anthem Customizations to MCG care guideline 24th Edition

Effective July 1, 2020, the following MCG care guideline 24th edition customizations will be implemented.

  • Carotid Artery Stenting (W0165) – Clinical Indications were customized to reference CG-SURG-76 Carotid, Vertebral and Intracranial Artery Stent Placement with or without Angioplasty
  • Deep Brain Stimulation (W0164) – Clinical Indications were customized to refer to SURG.00026 Deep Brain, Cortical, and Cerebellar Stimulation.
  • Vagus Nerve Stimulation, Implantable (W0166) – Clinical Indications were customized to refer to SURG.00007 Vagus Nerve Stimulation.

 

View a detailed summary of customizations here. Scroll down to other criteria section and select Customizations to MCG Care Guidelines 24th Edition.

 

For questions, please contact the provider service number on the back of the member's ID card.

PharmacyCommercialApril 1, 2020

Anthem to delay most 4/1/2020 formulary list updates for commercial health plan pharmacy benefit

In light of the current situation with COVID-19, we have decided to delay the implementation of many of the previously-communicated formulary changes scheduled for April 1, 2020.

 

The changes listed below will still go into effect on 4/1/2020:

 

 

National/Preferred Drug List

Traditional Open

Drug List

Essential

Drug List

Antihistamines

 

 

 

carbinoxamine 6mg

Tier 1 -> NF

Tier 1 -> Tier 3

Tier 1 -> NF

Topical Anesthetics

 

 

 

Lidocaine 7%-Tetracaine 7% cream

Tier 3/NF -> NF

Tier 3 (No Change)

NF (No Change)

Pliaglis cream

Tier 3/NF -> NF

Tier 3 (No Change)

NF (No Change)

 

Please note, this update does not apply to the Select Drug List and does not impact Medicaid and Medicare plans.

PharmacyCommercialApril 1, 2020

Pharmacy information available on anthem.com

For more information on copayment/coinsurance requirements and their applicable drug classes, drug lists and changes, prior authorization criteria, procedures for generic substitution, therapeutic interchange, step therapy or other management methods subject to prescribing decisions, and any other requirements, restrictions, or limitations that apply to using certain drugs, visit anthem.com/pharmacyinformation. The commercial and marketplace drug lists are posted to the web site quarterly (the first of the month for January, April, July and October).

 

To locate “Marketplace Select Formulary” and pharmacy information, scroll down to “Select Drug Lists.” This drug list is also reviewed and updated regularly as needed.

 

FEP Pharmacy updates and other pharmacy related information may be accessed at fepblue.org > Pharmacy Benefits.

PharmacyCommercialApril 1, 2020

Anthem prior authorization updates for specialty pharmacy are available

Prior authorization updates

Effective for dates of service on and after July 1, 2020, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our prior authorization review process.

Please note, inclusion of NDC code on your claim will shorten the claim processing time of drugs billed with a Not Otherwise Classified (NOC) code.

To access the clinical criteria document information please click here.  

 

Anthem’s prior authorization clinical review of non-oncology specialty pharmacy drugs will be managed by Anthem’s medical specialty drug review team. Review of specialty pharmacy drugs for oncology indications will be managed by AIM Specialty Health® (AIM), a separate company and are in italics.

Clinical Criteria

HCPCS or CPT Code(s)

Drug

*ING-CC-0003

C9399

J3490

J3590

Xembify

ING-CC-0062

J3590

Eticovo

ING-CC-0062

J3490

Hadlima

ING-CC-0072

J0179

Bevou

ING-CC-0152

J3490

Vyondys 53

ING-CC-0153

C9399

J3490

J3590

Adakveo

ING-CC-0154

C9399

J3490

J3590

Givlaari

 

* Non-oncology use is managed by Anthem’s medical specialty drug review team; oncology use is managed by AIM.

 

Step therapy updates

Effective for dates of service on and after July 1, 2020, the attached specialty pharmacy codes from new or current clinical criteria will be included in our existing specialty pharmacy medical step therapy review process.

Orencia will be the non-preferred agent for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and psoriatic arthritis. The attached table will assist you in identifying the applicable preferred agents and clinical criteria.

To access the clinical criteria document information please click here.  

 

 

State Health Benefit PlanCommercialMarch 27, 2020

Provider COVID-19 update: State Health Benefit Plan

Effective immediately, the State Health Benefit Plan (SHBP) has elected to expand their telehealth coverage for members and to waive any member out-of-pocket costs for telehealth visits, including visits for mental health, for a temporary period. This means member out-of-pocket costs for Anthem’s telemedicine service, LiveHealth Online, and care received from other telehealth providers is waived. The expansion of telehealth services will allow for telephonic communication, video cell phone communication and audio & video technology, to help members easily connect with providers, while maintaining compliance with social distancing.

  

For the latest provider news from Anthem Blue Cross and Blue Shield, please visit Provider News Home. If you have specific questions on SHBP coverage for members, you can contact 855-641-4862, and then press 9.If you have any questions related to your contract, please contact your Anthem provider representative.

State & FederalMedicare AdvantageApril 1, 2020

Medical drug benefit Clinical Criteria updates November 2019

On November 15, 2019, the Pharmacy and Therapeutics (P&T) Committee approved Clinical Criteria applicable to the medical drug benefit for Anthem Blue Cross and Blue Shield. These policies were developed, revised or reviewed to support clinical coding edits.

 

The Clinical Criteria is publicly available on the provider websites, and the effective dates will be reflected in the Clinical Criteria Web Posting November 2019. Visit Clinical Criteria to search for specific policies.

 

For questions or additional information, use this email.

 

ABSCRNU-0124-20

State & FederalMedicare AdvantageApril 1, 2020

2020 Medicare risk adjustment provider trainings

The Medicare Risk Adjustment Regulatory Compliance team at Anthem Blue Cross and Blue Shield offers two provider training programs regarding Medicare risk adjustment and documentation guidelines. Information for each training is outlined below.

 

Medicare Risk Adjustment and Documentation Guidance (General)

  • When: The trainings will be offered the first Wednesday of each month from 1:00 p.m. to 2:00 p.m. ET (from January 8, 2020, to December 2, 2020).
  • Learning objective: This onboarding training will provide an overview of Medicare risk adjustment, including the Risk Adjustment Factor and the Hierarchical Condition Category (HCC) model, with guidance on medical record documentation and coding.
  • Credits: This live activity has been reviewed and is acceptable for up to 1 prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

For those interested in joining us to learn how providers play a critical role in facilitating the risk adjustment process, register for one of the monthly training sessions using the following link: Medicare Risk Adjustment and Documentation Guidance (General)

 

Note: Dates may be modified due to holiday scheduling.

 

Medicare Risk Adjustment, Documentation and Coding Guidance (Condition Specific)

  • When: The trainings will be offered on the third Wednesday of every other month from noon to 1:00 p.m. ET (from January 15, 2020, to November 18, 2020).
  • Learning objective: This training series will provide in-depth disease information pertaining to specific conditions, including an overview of their corresponding hierarchical condition categories (HCC), with guidance on documentation and coding.
  • Credits: This live series activity has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity

 

For those interested in joining us for this six-part training series, please see the list of topics and scheduled training dates below:

  1. Red Flag Hierarchical Condition Categories (HCCs), part one (January 15, 2020): register for a recording of the session: Training will cover HCCs most commonly reported in error as identified by CMS (Chronic Kidney Disease Stage 5, Ischemic or Unspecified Stroke, Cerebral Hemorrhage, Aspiration and Specified Bacterial Pneumonias, Unstable Angina and Other Acute Ischemic Heart Disease, End-Stage Liver Disease).
  2. Medicare Risk Adjustment Documentation and Coding Guidance: Red Flag HCC's Part 2 (March 18, 2020): Training will cover HCCs most commonly reported in error as identified by CMS (Atherosclerosis of the Extremities with Ulceration or Gangrene, Myasthenia Gravis/Myoneural Disorders and Guillain-Barre Syndrome, Drug/Alcohol Psychosis, Lung and Other Severe Cancers, Diabetes with Ophthalmologic or Unspecified Manifestation)
  3. Neoplasms (May 20, 2020)
  4. Acute, Chronic and Status Conditions (July 15, 2020)
  5. Diabetes Mellitus and Other Metabolic Disorders (September 16, 2020)
  6. Topic TBD (November 18, 2020): This Medicare risk adjustment webinar will cover the critical topics and updates that surface during the year

 

ABSCRNU-0125-20

State & FederalMedicare AdvantageApril 1, 2020

Medical drug benefit Clinical Criteria updates December 2019

On December 18, 2019, and December 23, 2019, the Pharmacy and Therapeutics (P&T) Committee approved Clinical Criteria applicable to the medical drug benefit for Anthem Blue Cross and Blue Shield. These policies were developed, revised or reviewed to support clinical coding edits.

 

The Clinical Criteria is publicly available on the provider websites, and the effective dates will be reflected in the Clinical Criteria Web Posting December 2019. Visit Clinical Criteria to search for specific policies.

 

For questions or additional information, use this email.*

 

* IngenioRx, Inc. is an independent company providing pharmacy benefit management services on behalf of Anthem Blue Cross and Blue Shield.

 

ABSCRNU-0130-20

State & FederalMedicare AdvantageApril 1, 2020

Keep up with Medicare news